Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Century Communities
CCS
$2.03B
| $4.13M | ﹤0.01% |
62,036
-64,731
| -51% | -$4.57M |
|
1702
Ligand Pharmaceuticals
LGND
$6.36B
| $4.12M | ﹤0.01% |
50,365
-14,154
| -22% | -$1.18M |
|
1703
DXC Technology
DXC
$1.73B
| $4.12M | ﹤0.01% |
105,725
-4,079
| -4% | -$146K |
|
1704
NCR Voyix
VYX
$1.14B
| $4.11M | ﹤0.01% |
146,910
+127,034
| +639% | +$3.52M |
|
1705
Cavco Industries
CVCO
$4.55B
| $4.1M | ﹤0.01% |
18,449
-6,432
| -26% | -$1.4M |
|
1706
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.09B
| $4.09M | ﹤0.01% |
15,240
+11,490
| +306% | +$758K |
|
1707
Essential Properties Realty Trust
EPRT
$6.62B
| $4.09M | ﹤0.01% |
151,128
-71,370
| -32% | -$1.85M |
|
1708
HUB Group
HUBG
$2.92B
| $4.08M | ﹤0.01% |
123,774
+39,254
| +46% | +$1.34M |
|
1709
Neogen
NEOG
$2.5B
| $4.07M | ﹤0.01% |
88,451
-14,319
| -14% | -$662K |
|
1710
Sabesp
SBS
$18.7B
| $4.07M | ﹤0.01% |
2,837,547
-238,494
| -8% | -$355K |
|
|
BRFS
1711
DELISTED
BRF SA
BRFS
| $4.07M | ﹤0.01% |
743,658
-301,044
| -29% | -$1.43M |
|
|
CCXI
1712
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.07M | ﹤0.01% |
+303,600
| New | +$7.48M |
|
|
SKX
1713
DELISTED
Skechers
SKX
| $4.06M | ﹤0.01% |
81,532
+39,822
| +95% | +$1.88M |
|
1714
ABM Industries
ABM
$2.84B
| $4.06M | ﹤0.01% |
91,510
-33,153
| -27% | -$1.66M |
|
1715
Valmont Industries
VMI
$9.53B
| $4.05M | ﹤0.01% |
17,178
+11,797
| +219% | +$2.85M |
|
1716
CALL
Ford
F
$55.7B
| $4.04M | ﹤0.01% |
271,800
+68,300
| +34% | +$908K |
|
|
PGM
1717
DELISTED
iPath Series B Bloomberg Platinum Subindex Total ReturnSM ETN
PGM
| $4.03M | ﹤0.01% |
80,000
| – | – |
|
1718
CALL
Royal Caribbean
RCL
$85.6B
| $4.01M | ﹤0.01% |
47,000
-98,500
| -68% | -$8.58M |
|
|
NVRO
1719
DELISTED
NEVRO CORP.
NVRO
| $4.01M | ﹤0.01% |
24,164
-21,166
| -47% | -$3.3M |
|
1720
iShares Core Moderate Allocation ETF
AOM
$1.78B
| $4M | ﹤0.01% |
88,859
+60,680
| +215% | +$2.7M |
|
|
LMRK
1721
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $4M | ﹤0.01% |
+313,756
| New | +$3.96M |
|
1722
PUT
Kohl's
KSS
$2.19B
| $3.97M | ﹤0.01% |
72,000
| – | – |
|
1723
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.3B
| $3.96M | ﹤0.01% |
+71,619
| New | +$3.95M |
|
1724
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
| $3.95M | ﹤0.01% |
105,224
-8,039
| -7% | -$301K |
|
1725
Q2 Holdings
QTWO
$3.92B
| $3.95M | ﹤0.01% |
38,493
-46,369
| -55% | -$4.64M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.